Free Trial
NASDAQ:BPYPO

Brookfield Property Partners (BPYPO) Stock Price, News & Analysis

Brookfield Property Partners logo
$15.10 -0.08 (-0.49%)
Closing price 03:24 PM Eastern
Extended Trading
$15.12 +0.02 (+0.13%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Brookfield Property Partners Stock (NASDAQ:BPYPO)

Advanced

Key Stats

Today's Range
$14.89
$15.20
50-Day Range
$14.36
$15.47
52-Week Range
$13.01
$17.10
Volume
4,455 shs
Average Volume
14,322 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.53%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BPYPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookfield Property Partners and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BPYPO Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Brookfield Property Partners LP Pref Share BPYPO
See More Headlines

BPYPO Stock Analysis - Frequently Asked Questions

Brookfield Property Partners' stock was trading at $13.60 on January 1st, 2025. Since then, BPYPO shares have increased by 11.1% and is now trading at $15.1050.

Shares of BPYPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Record date for 9/29 Dividend
9/02/2025
Ex-Dividend for 9/29 Dividend
9/02/2025
Dividend Payable
9/29/2025
Today
10/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Real Estate Services
Sub-Industry
Real Estate
Current Symbol
NASDAQ:BPYPO
CIK
1545772
Fax
N/A
Employees
29,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$7.92 billion
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BPYPO) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners